Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Jeffrey Kern

Concepts (290)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
25
2024
2344
2.490
 Why?
Receptor, ErbB-2
14
2019
326
2.460
 Why?
Neuregulin-1
9
2019
46
2.400
 Why?
Carcinoma, Non-Small-Cell Lung
17
2024
1052
1.730
 Why?
Lung
13
2019
3930
1.490
 Why?
Signal Transduction
10
2019
4925
1.120
 Why?
Respiratory Mucosa
4
2014
307
1.050
 Why?
Antineoplastic Agents, Immunological
3
2022
181
0.930
 Why?
Acute Lung Injury
3
2012
279
0.910
 Why?
Radiosurgery
2
2024
321
0.870
 Why?
Pneumonectomy
1
2024
151
0.790
 Why?
ErbB Receptors
7
2014
607
0.780
 Why?
Receptor, ErbB-3
6
2007
45
0.690
 Why?
Epithelium
2
2019
311
0.670
 Why?
Protein-Tyrosine Kinases
2
2019
432
0.660
 Why?
Adult Stem Cells
1
2019
39
0.640
 Why?
Small Cell Lung Carcinoma
1
2020
89
0.630
 Why?
Alveolar Epithelial Cells
1
2019
106
0.610
 Why?
Adenocarcinoma
5
2019
898
0.590
 Why?
Neuroendocrine Cells
2
2016
32
0.590
 Why?
Immunotherapy
2
2022
592
0.560
 Why?
Cell Transformation, Neoplastic
1
2019
328
0.550
 Why?
Neoplasm Staging
8
2024
1295
0.530
 Why?
Tomography, X-Ray Computed
7
2015
2535
0.530
 Why?
Neoplasm Proteins
1
2019
424
0.520
 Why?
STAT3 Transcription Factor
5
2009
195
0.480
 Why?
Interleukin-6
1
2019
720
0.470
 Why?
Adherens Junctions
1
2014
25
0.460
 Why?
B-Lymphocyte Subsets
1
2014
74
0.430
 Why?
Immunity, Humoral
1
2014
118
0.410
 Why?
Cell Adhesion
1
2014
452
0.410
 Why?
beta Catenin
1
2014
223
0.400
 Why?
Carcinoma, Squamous Cell
4
2019
626
0.400
 Why?
Pulmonary Fibrosis
2
2007
386
0.400
 Why?
Epithelial Cells
3
2011
1065
0.390
 Why?
Quality of Life
1
2024
2704
0.390
 Why?
Blood Coagulation Factors
1
2012
53
0.390
 Why?
Protein C
1
2012
47
0.380
 Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2012
19
0.380
 Why?
Smad3 Protein
1
2011
43
0.360
 Why?
Smad2 Protein
1
2011
38
0.360
 Why?
Trans-Activators
2
2004
388
0.350
 Why?
Transforming Growth Factor beta1
1
2011
157
0.340
 Why?
Neoplasms
3
2024
2470
0.340
 Why?
Receptors, Cell Surface
1
2012
380
0.340
 Why?
p38 Mitogen-Activated Protein Kinases
1
2011
274
0.330
 Why?
Bronchoalveolar Lavage Fluid
1
2012
644
0.320
 Why?
Lung Diseases
2
2016
742
0.320
 Why?
Epithelial-Mesenchymal Transition
1
2011
202
0.320
 Why?
Humans
46
2024
129650
0.310
 Why?
Early Detection of Cancer
1
2013
370
0.310
 Why?
Permeability
4
2014
157
0.310
 Why?
Quinazolines
5
2014
244
0.300
 Why?
Phosphorylation
6
2019
1713
0.300
 Why?
Prenylation
1
2008
3
0.290
 Why?
Antibodies, Monoclonal
5
2007
1367
0.290
 Why?
Piperidines
1
2008
199
0.250
 Why?
Protein Kinase Inhibitors
4
2014
891
0.250
 Why?
Tomography, Emission-Computed
2
2003
66
0.250
 Why?
DNA-Binding Proteins
2
2004
1443
0.250
 Why?
Epidermal Growth Factor
3
2012
171
0.240
 Why?
Drug Eruptions
2
2024
27
0.230
 Why?
Pyridines
1
2008
478
0.220
 Why?
Mass Screening
1
2012
1149
0.220
 Why?
Autocrine Communication
1
2004
43
0.220
 Why?
Thoracic Surgery, Video-Assisted
1
2024
43
0.220
 Why?
Morphogenesis
1
2004
158
0.210
 Why?
Mediastinal Neoplasms
1
2003
38
0.210
 Why?
Enzyme Inhibitors
2
2004
827
0.210
 Why?
Skin Diseases
2
2024
143
0.210
 Why?
Cell Line, Tumor
6
2019
3215
0.210
 Why?
Genetic Therapy
1
2005
292
0.200
 Why?
Milk Proteins
1
2002
33
0.200
 Why?
Phosphatidylinositol 3-Kinases
1
2004
359
0.200
 Why?
Aged, 80 and over
8
2024
7086
0.190
 Why?
Cisplatin
2
2020
300
0.190
 Why?
Cell Line
4
2014
2781
0.190
 Why?
ADAM17 Protein
2
2012
33
0.190
 Why?
Cell Proliferation
4
2015
2391
0.190
 Why?
Radiopharmaceuticals
1
2002
168
0.190
 Why?
Fluorodeoxyglucose F18
1
2002
129
0.180
 Why?
ADAM Proteins
2
2012
59
0.180
 Why?
Animals
10
2021
35361
0.180
 Why?
RNA Interference
2
2014
448
0.180
 Why?
CTLA-4 Antigen
1
2021
87
0.180
 Why?
Recombinant Proteins
3
2011
1304
0.170
 Why?
Female
15
2024
68776
0.170
 Why?
Etoposide
1
2020
148
0.170
 Why?
Enzyme Induction
1
2019
90
0.160
 Why?
RNA, Neoplasm
1
2019
88
0.160
 Why?
Tight Junctions
2
2014
75
0.160
 Why?
Receptors, Interleukin-6
1
2019
38
0.160
 Why?
Antigens
1
2021
355
0.160
 Why?
Programmed Cell Death 1 Receptor
1
2021
232
0.150
 Why?
Cells, Cultured
3
2019
4083
0.150
 Why?
B7-H1 Antigen
1
2021
196
0.150
 Why?
Sirolimus
1
2020
266
0.150
 Why?
Enzyme Activation
2
2014
811
0.150
 Why?
Transfection
3
2011
911
0.150
 Why?
Male
14
2024
63681
0.140
 Why?
Hyperplasia
2
2016
171
0.140
 Why?
Cell Lineage
1
2019
333
0.140
 Why?
Mice
6
2019
16937
0.140
 Why?
RNA, Messenger
3
2019
2708
0.140
 Why?
Middle Aged
9
2024
31154
0.140
 Why?
Xenograft Model Antitumor Assays
1
2020
814
0.140
 Why?
TOR Serine-Threonine Kinases
1
2020
396
0.140
 Why?
Aged
8
2024
22103
0.140
 Why?
Longitudinal Studies
1
2024
2717
0.130
 Why?
Antigen Presentation
1
2017
206
0.130
 Why?
Immunosuppressive Agents
1
2021
853
0.130
 Why?
Cytokines
1
2024
2017
0.130
 Why?
Lung Diseases, Obstructive
1
2016
46
0.130
 Why?
Treatment Outcome
4
2024
10230
0.130
 Why?
Tumor Cells, Cultured
4
2013
940
0.130
 Why?
Mutation
4
2014
3717
0.120
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2013
958
0.120
 Why?
Lymphocytes, Tumor-Infiltrating
1
2017
211
0.120
 Why?
Neoplastic Stem Cells
1
2019
380
0.120
 Why?
Research Report
1
2016
76
0.120
 Why?
Drug Synergism
2
2008
371
0.120
 Why?
Multiple Pulmonary Nodules
1
2015
19
0.120
 Why?
Bleomycin
2
2007
244
0.120
 Why?
Electric Impedance
1
2014
101
0.110
 Why?
ral GTP-Binding Proteins
1
2013
5
0.110
 Why?
Bronchiolitis
1
2015
90
0.110
 Why?
Tyrphostins
2
2004
17
0.110
 Why?
Medical Oncology
1
2016
272
0.110
 Why?
Forced Expiratory Volume
1
2015
510
0.110
 Why?
Transcriptome
1
2019
887
0.110
 Why?
Protein Binding
1
2019
2121
0.100
 Why?
ras Proteins
1
2013
144
0.100
 Why?
Time Factors
3
2011
6556
0.100
 Why?
T-Lymphocytes
1
2021
1928
0.100
 Why?
Blotting, Western
3
2013
1205
0.100
 Why?
Radiography, Thoracic
1
2013
168
0.100
 Why?
RNA, Small Interfering
1
2014
587
0.100
 Why?
History, 20th Century
1
2013
291
0.100
 Why?
B-Lymphocytes
1
2017
815
0.100
 Why?
Tomography, Spiral Computed
1
2011
27
0.090
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2012
147
0.090
 Why?
Cell Division
2
2004
797
0.090
 Why?
Cell Shape
1
2011
56
0.090
 Why?
Biopsy, Needle
1
2011
189
0.090
 Why?
Blood-Air Barrier
1
2011
10
0.090
 Why?
CD4-Positive T-Lymphocytes
1
2017
1056
0.090
 Why?
Collagen Type I
1
2011
119
0.090
 Why?
Fibronectins
1
2011
123
0.090
 Why?
Survival Rate
4
2013
1877
0.090
 Why?
Cellular Senescence
1
2012
181
0.090
 Why?
Bronchoscopy
1
2011
216
0.090
 Why?
Proto-Oncogene Proteins
1
2013
638
0.080
 Why?
Protein Inhibitors of Activated STAT
1
2009
6
0.080
 Why?
Cadherins
1
2011
188
0.080
 Why?
Vena Cava, Superior
1
2009
22
0.080
 Why?
Coronary Vessel Anomalies
1
2009
32
0.080
 Why?
Pulmonary Alveoli
1
2012
400
0.080
 Why?
Disease Models, Animal
2
2011
4063
0.080
 Why?
Global Health
1
2011
329
0.080
 Why?
Transcriptional Activation
1
2011
366
0.080
 Why?
Asthma
1
2022
2230
0.080
 Why?
Interleukin-1beta
1
2011
372
0.080
 Why?
Delivery of Health Care
1
2016
894
0.080
 Why?
Antigens, CD
1
2011
489
0.070
 Why?
Electronic Health Records
1
2016
975
0.070
 Why?
Colorimetry
1
2008
12
0.070
 Why?
Oncogene Protein v-akt
1
2008
24
0.070
 Why?
Occupational Exposure
1
2011
299
0.070
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2008
69
0.070
 Why?
Molecular Chaperones
1
2009
182
0.070
 Why?
Mesothelioma
1
2008
38
0.070
 Why?
Indicators and Reagents
1
2008
109
0.070
 Why?
Abnormalities, Multiple
1
2009
178
0.070
 Why?
Respiration, Artificial
1
2012
613
0.070
 Why?
Antimetabolites, Antineoplastic
1
2008
91
0.070
 Why?
Pulmonary Disease, Chronic Obstructive
2
2012
985
0.070
 Why?
Azacitidine
1
2008
139
0.070
 Why?
Comorbidity
1
2011
1547
0.070
 Why?
Contrast Media
1
2009
394
0.070
 Why?
Randomized Controlled Trials as Topic
1
2012
1368
0.060
 Why?
Nitrates
1
2006
89
0.060
 Why?
DNA, Complementary
1
2006
270
0.060
 Why?
Prognosis
5
2017
3794
0.060
 Why?
Mice, Inbred C57BL
2
2007
5440
0.060
 Why?
Lymphatic Metastasis
2
2003
320
0.060
 Why?
Oxidative Stress
1
2012
1269
0.060
 Why?
Gene Expression Regulation, Neoplastic
3
2009
1356
0.060
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2014
1565
0.060
 Why?
Biomarkers
2
2017
3973
0.060
 Why?
Collagen
1
2007
434
0.060
 Why?
Adult
7
2024
35576
0.060
 Why?
Case-Control Studies
1
2012
3381
0.060
 Why?
Survival Analysis
2
2005
1274
0.060
 Why?
Flavonoids
1
2004
78
0.060
 Why?
Organ Culture Techniques
1
2004
154
0.060
 Why?
Pruritus
1
2024
58
0.060
 Why?
Inhibitory Concentration 50
1
2004
86
0.060
 Why?
Flow Cytometry
1
2008
1156
0.050
 Why?
Protein Processing, Post-Translational
1
2006
455
0.050
 Why?
Exanthema
1
2024
74
0.050
 Why?
Eczema
1
2024
67
0.050
 Why?
Biopsy, Fine-Needle
1
2003
68
0.050
 Why?
Psoriasis
1
2024
87
0.050
 Why?
Drug Combinations
1
2004
330
0.050
 Why?
Apoptosis
2
2013
2503
0.050
 Why?
Predictive Value of Tests
3
2005
1952
0.050
 Why?
DNA Methylation
1
2008
607
0.050
 Why?
Kinetics
1
2006
1642
0.050
 Why?
Janus Kinase 3
1
2002
18
0.050
 Why?
Base Sequence
1
2006
2142
0.050
 Why?
Janus Kinase 1
1
2002
24
0.050
 Why?
STAT6 Transcription Factor
1
2002
26
0.050
 Why?
Iowa
1
2002
24
0.050
 Why?
Histoplasmosis
1
2002
14
0.050
 Why?
STAT5 Transcription Factor
1
2002
48
0.050
 Why?
Lymph Nodes
2
2002
472
0.050
 Why?
Endosonography
1
2003
143
0.050
 Why?
Prospective Studies
3
2022
7133
0.050
 Why?
Heart Defects, Congenital
1
2009
758
0.050
 Why?
Antineoplastic Agents
2
2005
2061
0.050
 Why?
Carcinoembryonic Antigen
1
2002
41
0.050
 Why?
Cell Polarity
1
2003
140
0.050
 Why?
Genes, p53
1
2002
70
0.050
 Why?
Tyrosine
1
2002
223
0.050
 Why?
Inflammation
1
2012
2736
0.050
 Why?
Biopsy
3
2016
1097
0.050
 Why?
Neoplasm Metastasis
1
2003
610
0.050
 Why?
Protein Transport
1
2002
428
0.040
 Why?
United States
2
2022
13903
0.040
 Why?
Fatigue
1
2022
318
0.040
 Why?
Steroids
1
2021
158
0.040
 Why?
Biomarkers, Tumor
1
2006
1181
0.040
 Why?
Drug Resistance, Neoplasm
3
2014
759
0.040
 Why?
Mice, Transgenic
1
2005
2119
0.040
 Why?
Skin
1
2024
725
0.040
 Why?
Cell Nucleus
1
2002
582
0.040
 Why?
Immunologic Factors
1
2021
231
0.040
 Why?
Diagnosis, Differential
1
2002
1434
0.040
 Why?
DNA
1
2004
1400
0.040
 Why?
Sensitivity and Specificity
1
2002
1838
0.030
 Why?
Retrospective Studies
1
2015
14518
0.030
 Why?
Lymphocyte Count
1
2017
148
0.030
 Why?
Antigen-Presenting Cells
1
2017
150
0.030
 Why?
Immunophenotyping
1
2017
311
0.030
 Why?
Disease Progression
2
2016
2635
0.030
 Why?
Prevalence
1
2002
2564
0.030
 Why?
Aniline Compounds
1
2014
98
0.030
 Why?
Lymphocyte Activation
1
2017
1106
0.030
 Why?
Tumor Microenvironment
1
2017
634
0.030
 Why?
Immunoenzyme Techniques
1
2013
213
0.030
 Why?
Nitriles
1
2014
172
0.030
 Why?
Quinolines
1
2014
156
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2013
331
0.030
 Why?
Proto-Oncogene Proteins p21(ras)
1
2013
259
0.020
 Why?
Protein Kinases
1
2014
318
0.020
 Why?
Mice, Nude
1
2013
683
0.020
 Why?
Pregnancy
1
2004
6402
0.020
 Why?
Sequence Analysis, RNA
1
2014
429
0.020
 Why?
Chronic Disease
1
2016
1720
0.020
 Why?
Communication
1
2016
846
0.020
 Why?
Computational Biology
1
2014
599
0.020
 Why?
Electrophoretic Mobility Shift Assay
1
2009
83
0.020
 Why?
Immunoprecipitation
1
2009
157
0.020
 Why?
Angiography
1
2009
195
0.020
 Why?
Fatal Outcome
1
2009
300
0.020
 Why?
Plasmids
1
2009
358
0.020
 Why?
Immunohistochemistry
2
2003
1698
0.020
 Why?
Registries
1
2016
1896
0.020
 Why?
Cyclin-Dependent Kinase 4
1
2007
44
0.020
 Why?
Up-Regulation
1
2009
840
0.020
 Why?
Structure-Activity Relationship
1
2007
548
0.020
 Why?
Echocardiography
1
2009
629
0.020
 Why?
Mediastinoscopy
1
2005
5
0.010
 Why?
Polymerase Chain Reaction
1
2008
1038
0.010
 Why?
Trastuzumab
1
2005
101
0.010
 Why?
Kaplan-Meier Estimate
1
2006
857
0.010
 Why?
Transcription, Genetic
1
2009
1418
0.010
 Why?
Electric Conductivity
1
2003
94
0.010
 Why?
Multivariate Analysis
1
2006
1502
0.010
 Why?
Infant
1
2016
9024
0.010
 Why?
Hypoxia
1
2009
1084
0.010
 Why?
Trachea
1
2003
220
0.010
 Why?
Immunoassay
1
2002
107
0.010
 Why?
Ligands
1
2003
622
0.010
 Why?
Risk Assessment
1
2009
3240
0.010
 Why?
Antibodies, Monoclonal, Humanized
1
2005
759
0.010
 Why?
Rats, Sprague-Dawley
1
2003
2406
0.010
 Why?
Calcium
1
2003
1213
0.010
 Why?
Wounds and Injuries
1
2003
711
0.010
 Why?
Rats
1
2003
5500
0.010
 Why?
Kern's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (290) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)